Is an alternative drug delivery system needed for docetaxel? The role of controlling epimerization in formulations and beyond (Q39140852)

9 September 2017

title

Is an alternative drug delivery system needed for docetaxel? The role of controlling epimerization in formulations and beyond (English)

1 reference

9 September 2017

1 reference

Arehalli S Manjappa

1

1 reference

9 September 2017

Peeyush N Goel

2

1 reference

9 September 2017

Makam P Vekataraju

3

1 reference

9 September 2017

Kesarla S Rajesh

4

1 reference

9 September 2017

Kinjal Makwana

5

1 reference

9 September 2017

Mukesh Ukawala

6

1 reference

9 September 2017

Yuvraj Nikam

7

1 reference

9 September 2017

Rajiv P Gude

8

1 reference

9 September 2017

Rayasa S Ramachandra Murthy

9

1 reference

9 September 2017

publication date

12 June 2013

1 reference

9 September 2017

published in

Pharmaceutical Research

1 reference

9 September 2017

volume

30

1 reference

9 September 2017

issue

10

1 reference

9 September 2017

page(s)

2675-2693

1 reference

Relationships between the structure of taxol analogs and their antimitotic activity

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Isolation and characterization of impurities in docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Docetaxel (Taxotere) is not metabolized by recombinant human CYP1B1 in vitro, but acts as an effector of this isozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Cytochrome P450 CYP1B1 protein expression: a novel mechanism of anticancer drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Synthesis and evaluation of water-soluble docetaxel prodrugs-docetaxel esters of malic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Fixed erythrodysaesthesia plaque due to intravenous injection of docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

A transferrin receptor-targeted liposomal formulation for docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

In vitro modulation of doxorubicin and docetaxel antitumoral activity by methyl-beta-cyclodextrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Preparation and pharmacokinetics of docetaxel based on nanostructured lipid carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

A stability-indicating HPLC assay method for docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Sustained ophthalmic in situ gel of ketorolac tromethamine: rheology and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Colorimetric determination of phospholipids with ammonium ferrothiocyanate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Self-assembly and characterization of paclitaxel-loaded N-octyl-O-sulfate chitosan micellar system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Paclitaxel nanoparticles for the potential treatment of brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Unravelling the antimetastatic potential of pentoxifylline, a methylxanthine derivative in human MDA-MB-231 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Ligustrazine inhibits B16F10 melanoma metastasis and suppresses angiogenesis induced by Vascular Endothelial Growth Factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Evaluation of the pharmaceutical quality of docetaxel injection using new stability indicating chromatographic methods for assay and impurities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

The choice of a suitable oligosaccharide to prevent aggregation of PEGylated nanoparticles during freeze thawing and freeze drying.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Interactions of liposomes with serum proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Docetaxel for treatment of solid tumours: a systematic review of clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Nanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Antibody derivatization and conjugation strategies: Application in preparation of stealth immunoliposome to target chemotherapeutics to tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Guidelines and pharmacopoeial standards for pharmaceutical impurities: overview and critical assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-013-1093-5

Evidence for the conversion of docetaxel into 7'-epidocetaxel in patients receiving Taxotere-based conventional chemotherapy.

21 January 2018

1 reference

12 December 2020

Effects of heating conditions on the glass transition parameters of amorphous sucrose produced by melt-quenching

1 reference

12 December 2020

Acid pH in tumors and its potential for therapeutic exploitation

1 reference

12 December 2020

Interference by lipids in the determination of protein using bicinchoninic acid

1 reference

12 December 2020

Evaluation of antimetastatic activity and systemic toxicity of camptothecin-loaded microspheres in mice injected with B16-F10 melanoma cells

1 reference

12 December 2020

Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes

1 reference

12 December 2020

Isolation and characterization of degradation impurities in docetaxel drug substance and its formulation

1 reference

12 December 2020

Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes

1 reference

12 December 2020

Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.

1 reference

12 December 2020

Suppression of tumorigenicity and metastasis in B16F10 cells by PTEN/MMAC1/TEP1 gene

1 reference

12 December 2020

A liposomal formulation able to incorporate a high content of Paclitaxel and exert promising anticancer effect

1 reference

12 December 2020

Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukemia

1 reference

12 December 2020

Diffusion of univalent ions across the lamellae of swollen phospholipids

1 reference

12 December 2020

Effect of phospholipid composition on characterization of liposomes containing 9-nitrocamptothecin

1 reference

12 December 2020

10.1007/S11095-013-1093-5

Identifiers

DOI

1 reference

9 September 2017

1 reference